CDP Venture Capital

CDP Venture Capital, established in 2015 and based in Rome, Italy, is a prominent venture capital investment firm dedicated to fostering innovation and economic development within the country. The firm aims to enhance the venture capital ecosystem by investing in startups and growth companies across a diverse range of sectors, including consumer products, energy, healthcare, information technology, automotive, fashion, food, fintech, insur-tech, advanced manufacturing, agriculture materials, education, big data, life sciences, financial services, software-as-a-service, virtual reality, artificial intelligence, and machine learning. By prioritizing these industries, CDP Venture Capital seeks to create sustainable growth and support the overall development of Italy's entrepreneurial landscape.

Alessandro Angeletti

Investment Manager

Hagaj Badash

Investment Manager

Cristina Bini

Senior Partner

Filippo Bosco Ph.D

Partner

Simona Corno

Senior Partner

Daniele Genovesi

Senior Partner and Fund Manager

francesco grassi

Investment Manager

Elisa Grasso

Senior Investment Manager

Federico Lanciano

Partner

Niccolò Mussi

Investment Manager

Davide Opromolla

Senior Investment Manager

Matteo Pozzi

Partner, Head of InfraTech Portfolio

Ersilia Rendola

Partner

Francesco Rossi

Senior Investment Manager

Davide Santi

Senior Investment Manager

Mario Scuderi

Partner

Giacomo Valentini

Senior Partner

Alessandro Vasconi

Associate

Rita Verderosa

Partner

Rebecca d'aloja

Associate

Past deals in Medical Devices

GenomeUp

Venture Round in 2025
GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support in disease management. Its mission is to establish a global reference platform that aids clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By leveraging advanced technology, GenomeUp aims to accelerate diagnosis times, enhance patient care, and contribute to health prevention efforts, all within a 24-hour timeframe. Committed to social responsibility, the founders have transformed GenomeUp into an Italian Benefit Corporation, emphasizing sustainability, transparency, and a focus on the well-being of stakeholders, communities, and the environment.

Salute360

Seed Round in 2025
Salute360 is an online healthcare platform dedicated to providing reliable healthcare information and a variety of related services. The platform allows patients to book healthcare consultations and order medicines for home delivery within hours. Additionally, it facilitates connections between patients and local pharmacists and healthcare professionals, ensuring that healthcare services are easily available, affordable, and accessible.

Genoa Instruments

Venture Round in 2025
Genoa Instruments is a startup focused on advancing biomedical and health research through its innovative super-resolution optical microscopy technology. The company has developed a unique platform that integrates spatial and temporal super-resolution capabilities, allowing for detailed structural and functional imaging of living samples. Its offerings include a plug-and-play kit for image-scanning microscopy and next-generation confocal microscopy, enabling researchers to conduct quantitative studies using fluorescence optical microscopy. By making high-resolution imaging more accessible, Genoa Instruments aims to foster scientific discovery and enhance healthcare research.

EBAMed

Series A in 2025
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

Restorative Neurotechnologies

Series A in 2024
Restorative Neurotechnologies S.R.L., founded in 2018 and based in Palermo, Italy, specializes in the design and development of non-invasive neuromodulation devices aimed at cognitive rehabilitation. The company focuses on creating innovative medical devices that assist in the rehabilitation of cognitive disorders and enhance cognitive performance. By providing solutions that can be utilized in both clinical and athletic settings, Restorative Neurotechnologies enables medical professionals to support patients and athletes in their recovery and performance improvement efforts.

Lymphatica Medtech

Series B in 2024
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.

Genespire

Series B in 2024
Genespire is a biotechnology company dedicated to advancing gene therapies for individuals suffering from genetic disorders, with a specific emphasis on primary immunodeficiencies and inherited metabolic diseases. The company specializes in developing innovative therapies that utilize integration-defective lentiviral vectors combined with gene editing techniques. This approach allows for the precise and effective insertion of therapeutic genes into blood cells, providing patients with a range of tailored treatment options suitable for their unique conditions. Genespire's mission is to transform the lives of patients affected by severe genetic diseases through cutting-edge therapeutic solutions.

BionIT Labs

Venture Round in 2024
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.

Agade

Venture Round in 2023
Agade specializes in the development of robotic exoskeletons aimed at reducing muscle fatigue and minimizing the risk of injuries linked to repetitive and dynamic tasks. Their flagship product, AGADEXO, is designed to provide variable support for upper limb movements, effectively counteracting the effects of gravity and allowing for more efficient motion, akin to operating in a zero-gravity environment. The exoskeleton is compact and energy-efficient, consuming minimal power comparable to that of medium-intensity LED bulbs. This innovative technology is particularly beneficial for operators engaged in pick and place tasks, enhancing productivity while safeguarding against the physical strain associated with their work.

MindAhead

Pre Seed Round in 2023
MindAhead is a company focused on digital health and med tech, specifically aimed at improving brain health. It has developed a healthcare tool that facilitates the early detection of cognitive impairment through regular checks of cognitive health. Positioned as the first therapy tool for individuals with mild cognitive impairment, MindAhead's solution is designed to prevent or slow the onset of dementia while enhancing the quality of life for its users. The company's application software offers a science-based program tailored to individual brain health needs, providing support and resources for patients to manage their cognitive health effectively.

Salute360

Pre Seed Round in 2022
Salute360 is an online healthcare platform dedicated to providing reliable healthcare information and a variety of related services. The platform allows patients to book healthcare consultations and order medicines for home delivery within hours. Additionally, it facilitates connections between patients and local pharmacists and healthcare professionals, ensuring that healthcare services are easily available, affordable, and accessible.

BionIT Labs

Seed Round in 2021
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.

Neuron Guard

Seed Round in 2021
Neuron Guard SRL is an Italian medical device company founded in 2013 and headquartered in Modena. It focuses on developing an innovative device aimed at managing acute brain damage, a critical condition often resulting from cardiovascular diseases and traumatic brain injuries. The company's primary product is a refrigerating collar that works in conjunction with a smart control unit, allowing healthcare professionals to deliver targeted temperature management therapy. This device helps reduce neural lesions and preserve brain function, which can impact vital abilities such as speech, vision, and movement. Neuron Guard’s solution is designed for use both in hospital settings and in emergency situations, enabling immediate temperature regulation of patients. The device is equipped with a disposable protective shield for hygiene and safety, and it connects to an Emergency Response System to transmit vital patient data. Neuron Guard aims to establish its device as a standard of care for temperature management in acute medical conditions, with a vision of making it as accessible as automated external defibrillators in public spaces. The company has conducted extensive testing and holds patents in several countries.

Weart

Venture Round in 2021
Weart specializes in haptic technology aimed at digitalizing the sense of touch, enhancing experiences in virtual and augmented reality. The company develops wearable and portable devices that enable users to experience realistic tactile sensations, including texture, temperature, and forces. This technology allows for the recording and reproduction of tactile interactions, facilitating immersive VR training sessions in fields like medicine and industry, as well as improving in-store shopping and e-commerce by providing users with a more engaging experience. By merging concepts from science fiction with practical applications, Weart creates innovative solutions that enhance user interaction with digital environments.

Existo S.r.l.

Seed Round in 2021
Existo S.r.l. is a developer of innovative wearable technology aimed at enhancing human capabilities in daily living. The company's flagship product, Sixto, is a sixth robotic finger that serves as a wearable grasping device. Sixto features a single degree of freedom, allowing it to create a hybrid grasping mechanism that integrates with the user's hand. This technology not only augments the hand's grasping ability but also provides an intelligent holding point and can be personalized with interchangeable modules to suit various needs. Additionally, Sixto enables users to extend their grip away from the hand, making it particularly useful in potentially hazardous environments. The device is designed to assist individuals with disabilities by compensating for missing hand functions and improving overall functional scope.

GreenBone Ortho

Series B in 2021
GreenBone specializes in the development of innovative bone implants derived from bamboo wood, designed to address severe fractures and conditions that lead to significant bone loss, such as trauma and tumors. The company’s technology transforms bamboo into hydroxyapatite, a widely utilized biomaterial that serves as a bone graft scaffold. These biomimetic, reabsorbable implants possess the necessary weight-bearing and bone regeneration properties to effectively treat non-union fractures. Founded by a research group from ISTEC-CNR of Faenza, GreenBone aims to provide bio-inspired solutions that can significantly improve patient outcomes in orthopedic care.

BionIT Labs

Pre Seed Round in 2021
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.

WISE

Series C in 2020
WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Restorative Neurotechnologies

Seed Round in 2020
Restorative Neurotechnologies S.R.L., founded in 2018 and based in Palermo, Italy, specializes in the design and development of non-invasive neuromodulation devices aimed at cognitive rehabilitation. The company focuses on creating innovative medical devices that assist in the rehabilitation of cognitive disorders and enhance cognitive performance. By providing solutions that can be utilized in both clinical and athletic settings, Restorative Neurotechnologies enables medical professionals to support patients and athletes in their recovery and performance improvement efforts.

InnovHeart

Series B in 2020
InnovHeart is a medical equipment manufacturing company that specializes in developing transcatheter mitral valve replacement systems. The company focuses on creating innovative implant technologies designed to treat patients with mitral valve disease. Its products aim to provide a safe, effective, and user-friendly solution for replacing incompetent mitral valves, allowing hospitals to address heart valve dysfunction more efficiently.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.